Page added to clipboard.

Dr. Jeffrey Bruce’s Paper on Brain Tumor Immunotherapy Presented at CNS 2013

Dr. Bruce CNS 2013
Dr. Jeffrey Bruce at the 2013 annual meeting of the Congress of Neurological Surgeons

Dr. Jeffrey BruceEdgar M. Housepian Professor of Neurological Surgery at Columbia University Medical Center, is one of the senior authors of a paper on brain tumor treatment that was presented at the recent annual meeting of the Congress of Neurological Surgeons (CNS).

The paper titled, Effect Of Pretreatment Lymphopenia On Survival In Patients With Recurrent Glioblastoma Receiving Immunotherapy, analyzed the impact of tumor-caused immune system suppression on the outcomes of patients receiving a brain tumor vaccine. They concluded that this can be a factor and “should be considered when selecting patients for future vaccine clinical trials.”

Co-authors of the paper included: Orin Bloch, Yelena S. Fuks, Manish Kumar Aghi, Michael William McDermott, Mitchel S. Berger, Andrew E. Sloan, Jeffrey N. Bruce, and Andrew T. Parsa.

Dr. Bruce is Columbia Neurosurgery’s Director of the Bartoli Brain Tumor Research Laboratory and Co-Director of their Brain Tumor Center and specializes in the burgeoning field of brain tumor immunotherapy. He is also on the advisory board of the CNS/AANS Joint Section on Tumors.

To learn more about Dr. Bruce, see his bio page here.

CNS 2013
Conference goers peruse CNS Original Science presentations

patient journey

Use this button to save pages to your clipboard for future use.

OK. Got it.